{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Faropenem Observations & Review Study in the Management of Complicated Urinary Tract Infections (FOR Study)

  1. How frequently do you encounter patients with complicated urinary tract infections (cUTIs) in your practice? *

  2. How do you diagnose a case of complicated UTI and differentiate it from uncomplicated UTI? *

  3. Patients you came across for cUTI is majorly associated with? *

  4. What percentage of your cUTI patients require hospitalization for treatment? *

  5. How often do you encounter patients with recurrent cUTIs in your practice? *

  6. How often do you encounter cases of cUTIs caused by multidrug-resistant organisms (MDROs) in your practice? *

  7. What is your preferred choice of antibiotic for treating cUTIs in adult patients? *

  8. Have you prescribed Faropenem for the treatment of cUTIs recently? *

  9. What are the main barriers to prescribing Faropenem for cUTIs in your practice? *

  10. What factors influence your decision to prescribe Faropenem in cUTIs? *

  11. What is your preferred duration of Faropenem therapy for cUTIs? *

  12. When do you prefer Faropenem in your practice for the management of cUTI? *

  13. In your experience, how effective is Faropenem in patients with comorbid conditions compared to those without? *

  14. How satisfied are you with the tolerability profile of Faropenem in patients with cUTIs? *

  15. In which type of patient populations Faropenem is not preferred by you? *

  16. Any specific monitoring is recommended by you for patients who are on Faropenem? *

  17. Which drug do you generally prefer as first-line therapy for UTIs? *

  18. As per your clinical experience what is your opinion about activity of Faropenem against E. coli and Klebsiella spp. with ESBLs which are the major causative organism for the development of cUTIs *

  19. Have you used a dosage regimen of Faropenem 300 mg three times a day for treating cUTIs? *

  20. In cUTI which antibiotic in your practice observed to be having least recurrence rate? *